TP53INP2
Tumor protein p53-inducible nuclear protein 2
Also known as: C20orf110, dJ1181N3.1, DKFZp434B2411, DKFZp434O0827, DOR, FLJ21759, FLJ23500, PINH, T53I2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXH6
- Gene
- TP53INP2
- Ensembl
- ENSG00000078804
- Chromosome
- 20
- Canonical length
- 220 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene promotes autophagy and is essential for proper autophagosome formation and processing. In addition, the encoded protein can enhance rDNA transcription by helping in the assembly of the POLR1/RNA polymerase I preinitiation complex. Finally, this protein serves as a transcriptional activator for some genes. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
220 residues, UniProt reviewed canonical sequence.
>Q8IXH6|TP53INP2
1 MFQRLSSLFF STPSPPEDPD CPRAFVSEED EVDGWLIIDL PDSYAAPPSP GAAPAPAGRP
61 PPAPSLMDES WFVTPPACFT AEGPGLGPAR LQSSPLEDLL IEHPSMSVYV TGSTIVLEPG
121 SPSPLPDAAL PDGDLSEGEL TPARREPRAA RHAAPLPARA ALLEKAGQVR RLQRARQRAE
181 RHALSAKAVQ RQNRARESRP RRSKNQSSFI YQPCQRQFNYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TP53INP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 888 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 888 nTPM
- midbrain: 633 nTPM
- hippocampal formation: 373 nTPM
- hypothalamus: 308 nTPM
- amygdala: 306 nTPM
- basal ganglia: 300 nTPM
Single-cell type
- late spermatids: 585 nCPM
- esophageal apical cells: 326 nCPM
- early spermatids: 261 nCPM
- colonocytes: 117 nCPM
- neutrophils: 103 nCPM
- goblet cells: 85 nCPM
Immune cell
- neutrophil: 2.7 nTPM
- eosinophil: 0.6 nTPM
- basophil: 0.5 nTPM
- plasmacytoid DC: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
- classical monocyte: 0 nTPM
Brain region
- medulla oblongata: 802 nTPM
- white matter: 740 nTPM
- pons: 707 nTPM
- midbrain: 674 nTPM
- basal ganglia: 656 nTPM
- spinal cord: 634 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.81
- gnomAD missense Z
- 0.32
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- intracellular protein localization
- negative regulation of protein localization
- osteoblast differentiation
- positive regulation of DNA-templated transcription
- tissue homeostasis
- ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TP53INP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TP53INP2 as an antibody target. Whether an autoantibody or antibody against TP53INP2 could matter depends on whether native TP53INP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TP53INP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TP53INP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...